You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exon 53

Showing 1 - 25 of 507
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscular Dystrophy, Duchenne, DMD Trial (viltolarsen)

Approved for marketing
  • Muscular Dystrophy, Duchenne
  • DMD
  • (no location specified)
Aug 14, 2020

Duchenne Muscular Dystrophy Trial in Worldwide (Placebo, SRP-4053)

Completed
Has Results
  • Duchenne Muscular Dystrophy
  • Boston, Massachusetts
  • +4 more
Oct 14, 2020

Duchenne Muscular Dystrophy Trial in Worldwide (SRP-4045, SRP-4053, Placebo)

Active, not recruiting
  • Duchenne Muscular Dystrophy
  • Phoenix, Arizona
  • +74 more
Jan 17, 2023

Duchenne Muscular Dystrophy Trial in Worldwide (Viltolarsen, Placebo)

Recruiting
  • Duchenne Muscular Dystrophy
  • Sacramento, California
  • +38 more
May 23, 2022

Duchenne Muscular Dystrophy Trial in Columbus (Casimersen, Eteplirsen, Golodirsen)

Active, not recruiting
  • Duchenne Muscular Dystrophy
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 11, 2021

Duchenne Muscular Dystrophy Trial in Worldwide (Casimersen, Golodirsen)

Enrolling by invitation
  • Duchenne Muscular Dystrophy
  • Phoenix, Arizona
  • +49 more
Aug 3, 2022

Duchenne Muscular Dystrophy Trial in Canada, United States (NS-065/NCNP-01, Placebo)

Completed
Has Results
  • Duchenne Muscular Dystrophy
  • Sacramento, California
  • +6 more
Nov 12, 2021

NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Pemetrexed)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Phoenix, Arizona
  • +303 more
Aug 17, 2022

Duchenne Muscular Dystrophy Trial in Worldwide (Viltolarsen)

Enrolling by invitation
  • Duchenne Muscular Dystrophy
  • Westmead, Australia
  • +13 more
May 24, 2022

Duchenne Muscular Dystrophy Trial in Worldwide (Viltolarsen)

Active, not recruiting
  • Duchenne Muscular Dystrophy
  • Richmond, Virginia
  • +7 more
Jun 30, 2022

NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • MK-2870
  • +2 more
  • (no location specified)
Oct 3, 2023

NSCLC Trial in Guangzhou (PLB1001)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 15, 2023

Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 31, 2023

Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))

Recruiting
  • Duchenne Muscular Dystrophy
  • Phase 1, SQY51
  • +3 more
  • Garches, France
    Hôpital Raymond Poincaré
Mar 7, 2023

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

NSCLC Trial in Worldwide (Amivantamab, Osimertinib, Lazertinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Goodyear, Arizona
  • +266 more
Aug 17, 2022

Esophageal Cancer Trial in Daegu (chemoradiotherapy)

Recruiting
  • Esophageal Cancer
  • chemoradiotherapy
  • Daegu, Korea, Republic of
    Kyungpook National University Medical Canter
Aug 8, 2021

Advanced NSCLC Trial in Jinan (almonertinib)

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • Jinan, Shandong, China
    Degan Lu
Sep 12, 2023

Non Small Cell Lung Cancer Trial in Durham, Columbus, Pittsburgh (osimertinib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
  • +2 more
Jun 30, 2022

Labor Pain Trial in Naples (VR)

Completed
  • Labor Pain
  • VR
  • Naples, Italy
    University Federico II
May 18, 2023

NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Fairfax, Virginia
    NEXT Virginia
Sep 18, 2023

Labor Pain, Labor Fast, Satisfaction, Patient Trial in Istanbul (Birth ball, Squatting)

Completed
  • Labor Pain
  • +2 more
  • Birth ball
  • Squatting
  • Istanbul, Turkey
    Istanbul University-Cerrahpasa
Jul 26, 2022

NSCLC (NSCLC) Trial in Japan, United States (Patritumab deruxtecan, Osimertinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Santa Monica, California
  • +13 more
Feb 1, 2023

Duchenne Muscular Dystrophy (DMD) Trial in United States (eteplirsen)

Completed
Has Results
  • Duchenne Muscular Dystrophy (DMD)
  • Phoenix, Arizona
  • +36 more
Dec 31, 2020

Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

Not yet recruiting
  • Myeloproliferative Neoplasms (MPNs)
  • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
  • (no location specified)
Mar 24, 2023